Incidence and risk factors for very late recurrence of atrial fibrillation after radiofrequency catheter ablation

Europace

Volumn 15, Issue 11, 2013, Pages 1581-1586

  Sotomi, Yohei ^a   Inoue, Koichi ^a   Ito, Norihisa ^a   Kimura, Ryusuke ^a   Toyoshima, Yuko ^a   Masuda, Masaharu ^a   Iwakura, Katsuomi ^a   Fujii, Kenshi ^a  

^a Diagnostic Cardiology and Radiology Department   (Japan)

Author keywords

Arrhythmogenic substrate; Atrial fibrillation; C reactive protein; Catheter ablation; Predictor; Pulmonary vein isolation; Very late recurrence

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATININE; BIOLOGICAL MARKER;

ADULT; ARTICLE; ATRIAL FIBRILLATION; CARDIOVERSION; CATHETER ABLATION; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC DYSFUNCTION; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INCIDENCE; LUNG ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MITRAL VALVE REGURGITATION; OBESITY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PULMONARY VEIN ISOLATION; RADIOFREQUENCY ABLATION; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; SUPRAVENTRICULAR TACHYCARDIA; TRANSTHORACIC ECHOCARDIOGRAPHY; AGED; ARRHYTHMOGENIC SUBSTRATE; HEART ATRIUM FIBRILLATION; METABOLISM; PREDICTOR; PROGNOSIS; VERY LATE RECURRENCE;

ARRHYTHMOGENIC SUBSTRATE; ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; CATHETER ABLATION; PREDICTOR; PULMONARY VEIN ISOLATION; VERY LATE RECURRENCE;

AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CATHETER ABLATION; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84898437828     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eut076     Document Type: Article

References (26)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-5.
2. Hohnloser SH, Kuck KH. Randomized trial of rhythm or rate control in atrial fibrillation: The Pharmacological Intervention in Atrial Fibrillation Trial (PIAF). Eur Heart J 2001;22:801-2.
3. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB et al. Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33.
4. Weerasooriya R, Khairy P, Litalien J, Macle L, Hocini M, Sacher F et al. Catheter ablation for atrial fibrillation: Are results maintained at 5 years of follow-up? J Am Coll Cardiol 2011;57:160-6.
5. Wokhlu A, Hodge DO, Monahan KH, Asirvatham SJ, Friedman PA, Munger TM et al. Long-term outcome of atrial fibrillation ablation: Impact and predictors of very late recurrence. J Cardiovasc Electrophysiol 2010;21:1071-8.
6. Tzou WS, Marchlinski FE, Zado ES, Lin D, Dixit S, Callans DJ et al. Long-term outcome after successful catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol 2010;3:237-42.
7. Sauer WH, McKernan ML, Lin D, Gerstenfeld EP, Callans DJ, Marchlinski FE. Clinical predictors and outcomes associated with acute return of pulmonary vein conduction during pulmonary vein isolation for treatment of atrial fibrillation. Heart Rhythm 2006;3:1024-8.
8. Gerstenfeld EP, Callans DJ, Dixit S, Zado E, Marchlinski FE. Incidence and location of focal atrial fibrillation triggers in patients undergoing repeat pulmonary vein isolation: Implications for ablation strategies. J Cardiovasc Electrophysiol 2003; 14:685-90.
9. Callans DJ, Gerstenfeld EP, Dixit S, Zado E, Vanderhoff M, Ren JF et al. Efficacy of repeat pulmonary vein isolation procedures in patients with recurrent atrial fibrillation. J Cardiovasc Electrophysiol 2004;15:1050-5.
10. Ouyang F, Antz M, Ernst S, Hachiya H, Mavrakis H, Deger FT et al. Recovered pulmonary vein conduction as a dominant factor for recurrent atrial tachyarrhythmias after complete circular isolation of the pulmonary veins: Lessons from double Lasso technique. Circulation 2005;111:127-35.
11. Ouyang F, Tilz R, Chun J, Schmidt B, Wissner E, Zerm T et al. Long-term results of catheter ablation in paroxysmal atrial fibrillation: Lessons from a 5-year follow-up. Circulation 2010;122:2368-77.
12. Tuan TC, Chang SL, Tsao HM, Tai CT, Lin YJ, Hu YF et al. The impact of age on the electroanatomical characteristics and outcome of catheter ablation in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2010;21:966-72.
13. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994;271:840-4.
14. Chamberlain AM, Agarwal SK, Folsom AR, Soliman EZ, Chambless LE, Crow R et al. A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study). Am J Cardiol 2011;107:85-91.
15. Conen D, Tedrow UB, Koplan BA, Glynn RJ, Buring JE, Albert CM. Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation 2009;119:2146-52.
16. Gami AS, Hodge DO, Herges RM, Olson EJ, Nykodym J, Kara T et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 2007;49:565-71.
17. Schnabel RB, Sullivan LM, Levy D, Pencina MJ, Massaro JM, D'Agostino RB Sr et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): A community-based cohort study. Lancet 2009;373:739-45.
18. Wang TJ, Parise H, Levy D, D'Agostino RB Sr, Wolf PA, Vasan RS et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 2004;292:2471-7.
19. Cai L, Yin Y, Ling Z, Su L, Liu Z, Wu J et al. Predictors of late recurrence of atrial fibrillation after catheter ablation. Int J Cardiol 2013;164:82-7.
20. Mainigi SK, Sauer WH, Cooper JM, Dixit S, Gerstenfeld EP, Callans DJ et al. Incidence and predictors of very late recurrence of atrial fibrillation after ablation. J Cardiovasc Electrophysiol 2007;18:69-74.
21. Shah AN, Mittal S, Sichrovsky TC, Cotiga D, Arshad A, Maleki K et al. Long-term outcome following successful pulmonary vein isolation: Pattern and prediction of very late recurrence. J Cardiovasc Electrophysiol 2008; 19:661-7.
22. Sotomi Y, Inoue K, Ito N, Kimura R, Toyoshima Y, Masuda M et al. Cause of very late recurrence of atrial fibrillation or flutter after catheter ablation for atrial fibrillation. Am J Cardiol 2013;111:552-6.
23. Wong CX, Abed HS, Molaee P, Nelson AJ, Brooks AG, Sharma G et al. Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J Am Coll Cardiol 2011;57:1745-51.
24. Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of atrial fibrillation: A systematic review of the published data. J Am Coll Cardiol 2007;50:2021-8.
25. Calkins H, Reynolds MR, Spector P, Sondhi M, Xu Y, Martin A et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: Two systematic literature reviews and meta-Analyses. Circ Arrhythm Electrophysiol 2009; 2:349-61.
26. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012;14:528-606.